Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia

Por Fathi, Amir T., Wander, Seth A., Blonquist, Traci M., Brunner, Andrew M., Amrein, Philip C., Supko, Jeffrey, Hermance, Nicole M., Manning, Amity L., Sadrzadeh, Hossein, Ballen, Karen K., Attar, Eyal C., Graubert, Timothy A., Hobbs, Gabriela, Joseph, Christelle, Perry, Ashley M., Burke, Meghan, Silver, Regina, Foster, Julia, Bergeron, Meghan, Ramos, Aura Y., Som, Tina T., Fishman, Kaitlyn M., McGregor, Kristin L., Connolly, Christine, Neuberg, Donna S., Chen, Yi-Bin
Publicado no Haematologica (2017)

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials

Por Crook, Derrick W., Walker, A. Sarah, Kean, Yin, Weiss, Karl, Cornely, Oliver A., Miller, Mark A., Esposito, Roberto, Louie, Thomas J., Stoesser, Nicole E., Young, Bernadette C., Angus, Brian J., Gorbach, Sherwood L., Peto, Timothy E. A.
Publicado em 2012

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

Por Ribrag, Vincent, Kim, Won Seog, Bouabdallah, Reda, Lim, Soon Thye, Coiffier, Bertrand, Illes, Arpad, Lemieux, Bernard, Dyer, Martin J. S., Offner, Fritz, Felloussi, Zakia, Kloos, Ioana, Luan, Ying, Vezan, Remus, Graef, Thorsten, Morschhauser, Franck
Publicado no Haematologica (2017)

Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide...

Por Ardizzoni, A., Pennucci, M. C., Danova, M., Viscoli, C., Mariani, G. L., Giorgi, G., Venturini, M., Mereu, C., Scolaro, T., Rosso, R.
Publicado em 1996

Effects of a strength training program on daily living in women with fibromyalgia

Por Cristina Maestre-Cascales, Ana Belén Peinado Lozano, Jesús Javier Rojo González
Publicado em 2019-12-01

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial

Por Abe, Masatoshi, Nishigori, Chikako, Torii, Hideshi, Ihn, Hironobu, Ito, Kei, Nagaoka, Makoto, Isogawa, Naoki, Kawaguchi, Isao, Tomochika, Yukiko, Kobayashi, Mihoko, Tallman, Anna M., Papp, Kim A.
Publicado no J Dermatol (2017)

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

Por Yamada, M, Kudoh, S, Fukuda, H, Nakagawa, K, Yamamoto, N, Nishimura, Y, Negoro, S, Takeda, K, Tanaka, M, Fukuoka, M
Publicado em 2002

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized...

Por Overton, Edgar Turner, Tebas, Pablo, Coate, Bruce, Ryan, Robert, Perniciaro, Amy, Dayaram, Yaswant K., De La Rosa, Guy, Baugh, Bryan P.
Publicado no HIV Clin Trials (2016)

The Painfulness of Active, But Not Sham, Transcranial Magnetic Stimulation Decreases Rapidly Over Time: Results from the Double-Blind Phase of the OPT-TMS Trial

Por Borckardt, Jeffrey J, Nahas, Ziad H., Teal, John, Lisanby, Sarah H., McDonald, William M., Avery, David, Durkalski, Valerie, Pavlicova, Martina, Long, James, Sackeim, Harold A., George, Mark S.
Publicado em 2013

A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous...

Por Baker, Valerie L., Jones, Christopher A., Doody, Kevin, Foulk, Russell, Yee, Bill, Adamson, G. David, Cometti, Barbara, DeVane, Gary, Hubert, Gary, Trevisan, Silvia, Hoehler, Fred, Jones, Clarence, Soules, Michael
Publicado em 2014

Safety and Efficacy of High-Dose Tamoxifen and Sulindac for Desmoid Tumor in Children: Results of a Children’s Oncology Group (COG) Phase II Study

Por Skapek, Stephen X., Anderson, James R., Hill, D. Ashley, Henry, David, Spunt, Sheri L., Meyer, William, Kao, Simon, Hoffer, Fredric A., Grier, Holcombe E., Hawkins, Douglas S., Raney, R. Beverly
Publicado no Pediatr Blood Cancer (2012)

Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Por Kirschbaum, Mark, Frankel, Paul, Popplewell, Leslie, Zain, Jasmine, Delioukina, Maria, Pullarkat, Vinod, Matsuoka, Deron, Pulone, Bernadette, Rotter, Arnold J., Espinoza-Delgado, Igor, Nademanee, Auayporn, Forman, Stephen J., Gandara, David, Newman, Edward
Publicado em 2011

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

Por Bondarenko, Igor M, Ingrosso, Antonella, Bycott, Paul, Kim, Sinil, Cebotaru, Cristina L
Publicado no BMC Cancer (2015)

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Por Spiera, Robert F, Gordon, Jessica K, Mersten, Jamie N, Magro, Cynthia M, Mehta, Mansi, Wildman, Horatio F, Kloiber, Stacey, Kirou, Kyriakos A, Lyman, Stephen, Crow, Mary K
Publicado em 2011

Efficacy and tolerability of 1- and 3-month leuprorelin acetate depot formulations (Eligard(®)/Depo-Eligard(®)) for advanced prostate cancer in daily practice: a Belgian prospective non-interventional study

Por Braeckman, Johan, Michielsen, Dirk
Publicado em 2014

A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem...

Por Mims, Alice S., Mishra, Anjali, Orwick, Shelley, Blachly, James, Klisovic, Rebecca B., Garzon, Ramiro, Walker, Alison R., Devine, Steven M., Walsh, Katherine J., Vasu, Sumithira, Whitman, Susan, Marcucci, Guido, Jones, Daniel, Heerema, Nyla A., Lozanski, Gerard, Caligiuri, Michael A., Bloomfield, Clara D., Byrd, John C., Piekarz, Richard, Grever, Michael R., Blum, William
Publicado no Haematologica (2018)

Treatment of Myelodysplastic Syndrome with Two Schedules and Doses of Oral Topotecan: A Randomized...

Por Grinblatt, David L., Yu, Daohai, Hars, Vera, Vardiman, James W., Powell, Bayard L., Nattam, Sreenivasa, Silverman, Lewis R., de Castro, Carlos, Stone, Richard M., Bloomfield, Clara D., Larson, Richard A.
Publicado em 2009

Phase 2 Trial of the CDK4 inhibitor Palbociclib (PD0332991) at 125 mg dose in Well-Differentiated or Dedifferentiated Liposarcoma

Por Dickson, Mark A., Schwartz, Gary K., Keohan, Mary Louise, D’Angelo, Sandra P., Gounder, Mrinal M., Chi, Ping, Antonescu, Cristina R., Landa, Jonathan, Qin, Li-Xuan, Crago, Aimee M., Singer, Samuel, Koff, Andrew, Tap, William D.
Publicado no JAMA Oncol (2016)

A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3′- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer

Por Heath, Elisabeth I, Heilbrun, Lance K, Li, Jing, Vaishampayan, Ulka, Harper, Felicity, Pemberton, Pam, Sarkar, Fazlul H
Publicado em 2010

Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene...

Por Sutani, A, Nagai, Y, Udagawa, K, Uchida, Y, Koyama, N, Murayama, Y, Tanaka, T, Miyazawa, H, Nagata, M, Kanazawa, M, Hagiwara, K, Kobayashi, K
Publicado em 2006